GGrantIndex
← Leaderboards

Michael C Heinrich

Portland Va Medical Center

$320,444
Attributed
$320,444
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $180K · FY200925
$200K$150K$100K$50K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$320,444 · 1
VA$0 · 2

By mechanism

R21$320,444 · 1
I01$0 · 2

Top collaborators

No co-investigators on record.

Most similar at Portland Va Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Mutation

Research focus

MutationMalignant NeoplasmsCell LineClinically RelevantTumorVeteransMutantCaringBudgetsStromal NeoplasmVariantMutagenesisLifeHealthcareLibrariesMedicalAmericanPathogenicityMalignant Breast NeoplasmDiagnosisGrowthProteinsClinically SignificantCancer Biology

Grant awards (15)

Functional profiling of germline SDH variants associated with cancer susceptibility$0
I01 · FY2025 · VA · contact PI
Functional profiling of germline SDH variants associated with cancer susceptibility$0
I01 · FY2024 · VA · contact PI
Functional profiling of germline SDH variants associated with cancer susceptibility$0
I01 · FY2023 · VA · contact PI
Novel models for functional profiling of germline SDH variants associated with cancer$140,456
R21 · FY2022 · CA · contact PI
Functional profiling of germline SDH variants associated with cancer susceptibility$0
I01 · FY2022 · VA · contact PI
Novel models for functional profiling of germline SDH variants associated with cancer$179,988
R21 · FY2021 · CA · contact PI
Functional profiling of germline SDH variants associated with cancer susceptibility$0
I01 · FY2021 · VA · contact PI
Regulation of oncogenic KIT by LMTK3$0
I01 · FY2019 · VA · contact PI
Regulation of oncogenic KIT by LMTK3$0
I01 · FY2018 · VA · contact PI
Regulation of oncogenic KIT by LMTK3$0
I01 · FY2017 · VA · contact PI
Regulation of oncogenic KIT by LMTK3$0
I01 · FY2016 · VA · contact PI
Mechanisms of Tyrosine Kinase Inhibitor Resistance in GI Stromal Tumors$0
I01 · FY2012 · VA · contact PI
Mechanisms of Tyrosine Kinase Inhibitor Resistance in GI Stromal Tumors$0
I01 · FY2011 · VA · contact PI
Mechanisms of Tyrosine Kinase Inhibitor Resistance in GI Stromal Tumors$0
I01 · FY2011 · VA · contact PI
Mechanisms of Tyrosine Kinase Inhibitor Resistance in GI Stromal Tumors$0
I01 · FY2009 · VA · contact PI